Published in Exp Neurol on July 01, 2004
Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol (2012) 1.99
Epidermal nerve fiber quantification in the assessment of diabetic neuropathy. Acta Histochem (2008) 1.29
Insulin resistance in the nervous system. Trends Endocrinol Metab (2012) 1.18
Retracted Intranasal insulin ameliorates experimental diabetic neuropathy. Diabetes (2009) 1.09
Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol Dis (2008) 1.06
Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin. J Peripher Nerv Syst (2013) 1.04
Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons. Endocrinology (2011) 1.01
Motor neuron trophic factors: therapeutic use in ALS? Brain Res Rev (2010) 0.98
Axonal regeneration induced by repetitive electrical stimulation of crushed optic nerve in adult rats. Jpn J Ophthalmol (2009) 0.98
Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease. Front Endocrinol (Lausanne) (2014) 0.98
Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes. Antioxid Redox Signal (2011) 0.97
Diabetes and the brain: oxidative stress, inflammation, and autophagy. Oxid Med Cell Longev (2014) 0.85
In vivo peripheral nervous system insulin signaling. J Peripher Nerv Syst (2013) 0.83
Peripheral neuropathy is associated with insulin resistance independent of metabolic syndrome. Diabetol Metab Syndr (2015) 0.80
Effect of Cholesterol Reduction on Receptor Signaling in Neurons. J Biol Chem (2015) 0.78
Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration? Curr Neuropharmacol (2014) 0.76
Peripheral Neuropathy in Mouse Models of Diabetes. Curr Protoc Mouse Biol (2016) 0.76
A Role for Insulin in Diabetic Neuropathy. Front Neurosci (2016) 0.75
Diabetic polyneuropathy, sensory neurons, nuclear structure and spliceosome alterations: a role for CWC22. Dis Model Mech (2017) 0.75
Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell (1980) 8.10
The DRASIC cation channel contributes to the detection of cutaneous touch and acid stimuli in mice. Neuron (2001) 3.56
Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol (2000) 3.33
The mammalian sodium channel BNC1 is required for normal touch sensation. Nature (2000) 3.30
Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ (2000) 2.91
Peripheral nerve function in sepsis and multiple organ failure. Chest (1991) 2.46
Identification of a major keratinocyte cell envelope protein, loricrin. Cell (1990) 2.25
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia (2009) 2.24
An acute axonal form of Guillain-Barré polyneuropathy. Brain (1986) 2.20
Heat flow and distribution during induction of general anesthesia. Anesthesiology (1995) 2.12
Cyclin partners determine Pho85 protein kinase substrate specificity in vitro and in vivo: control of glycogen biosynthesis by Pcl8 and Pcl10. Mol Cell Biol (1998) 2.04
Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. Neurology (2000) 1.96
Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica (2006) 1.96
Management of foreign bodies in the gastrointestinal tract: an analysis of 104 cases in children. Endoscopy (1999) 1.87
A medium-density genetic linkage map of the bovine genome. Mamm Genome (1997) 1.85
Critical illness myopathy. Muscle Nerve (2000) 1.82
Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia. Clin Pharmacol Ther (2008) 1.82
Neuropeptide FF and FMRFamide potentiate acid-evoked currents from sensory neurons and proton-gated DEG/ENaC channels. Neuron (2000) 1.81
Refractory neurosarcoidosis responding to infliximab. Neurology (2002) 1.72
Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett (2001) 1.56
Correction of cardiac defects through a right thoracotomy in children. J Thorac Cardiovasc Surg (1998) 1.52
Electrophysiological and biochemical evidence that DEG/ENaC cation channels are composed of nine subunits. J Biol Chem (1998) 1.49
A decline in glial cell-line-derived neurotrophic factor expression is associated with impaired regeneration after long-term Schwann cell denervation. Exp Neurol (2002) 1.49
Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation. J Med Genet (2005) 1.44
Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia. J Natl Cancer Inst (2012) 1.41
Propofol linearly reduces the vasoconstriction and shivering thresholds. Anesthesiology (1995) 1.39
Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia (2006) 1.35
Staphylococci-induced human platelet injury mediated by protein A and immunoglobulin G Fc fragment receptor. J Clin Invest (1979) 1.29
Patterns and predictors of personal exposure to indoor air pollution from biomass combustion among women and children in rural China. Indoor Air (2011) 1.28
Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras. Cancer Res (1997) 1.27
p53 and tumor necrosis factor alpha regulate the expression of a mitochondrial chloride channel protein. J Biol Chem (1999) 1.27
Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate (1997) 1.23
Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. J Clin Invest (1986) 1.17
Regulation of glycogen synthase. Identification of residues involved in regulation by the allosteric ligand glucose-6-P and by phosphorylation. J Biol Chem (2000) 1.17
The neurological complications of sepsis. Ann Neurol (1993) 1.15
Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes. Brain (2001) 1.15
Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity. Clin Pharmacol Ther (2010) 1.15
The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach. CMAJ (2000) 1.13
Rescue and regeneration of injured peripheral nerve axons by intrathecal insulin. Neuroscience (2006) 1.13
Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells. J Clin Endocrinol Metab (2001) 1.13
Optimizing the sterilization of PLGA scaffolds for use in tissue engineering. Biomaterials (2001) 1.13
Hypothermic hyperbaric lung preservation for twenty-four hours with replantation. J Thorac Cardiovasc Surg (1968) 1.13
Activated RHOA and peripheral axon regeneration. Exp Neurol (2008) 1.12
Response of Haemophilus somnus to iron limitation: expression and identification of a bovine-specific transferrin receptor. Microb Pathog (1990) 1.12
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci (2001) 1.10
Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia. Leukemia (2012) 1.10
The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. Brain (2000) 1.10
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia (2011) 1.08
Peptide inhibitors of DNA cleavage by tyrosine recombinases and topoisomerases. J Mol Biol (2000) 1.08
Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1. Leukemia (2009) 1.07
Expression of glial cell line-derived neurotrophic factor family of growth factors in peripheral nerve injury in rats. Neuroreport (2000) 1.07
In vivo proliferation, migration and phenotypic changes of Schwann cells in the presence of myelinated fibers. Neuroscience (2002) 1.06
Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46. J Virol (1997) 1.06
Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes. Cell Growth Differ (1994) 1.05
Intelligent visualization and exploration of time-oriented clinical data. Top Health Inf Manage (1999) 1.05
Genome scan implicates adhesion biological pathways in secondary leukemia. Leukemia (2007) 1.04
Membrane changes in human platelets induced by lipopolysaccharide endotoxin. Br J Haematol (1977) 1.04
Preparation of silver nanoparticles with antimicrobial activities and the researches of their biocompatibilities. J Mater Sci Mater Med (2010) 1.04
The significance of myoclonic status epilepticus in postanoxic coma. Neurology (1990) 1.04
Delayed peripheral nerve degeneration, regeneration, and pain in mice lacking inducible nitric oxide synthase. J Neuropathol Exp Neurol (2001) 1.02
Local nitric oxide synthase activity in a model of neuropathic pain. Eur J Neurosci (1998) 1.02
Alterations in murine keratinocyte differentiation induced by activated rasHa genes are mediated by protein kinase C-alpha. Cancer Res (1994) 1.02
Ischemic and reperfusion injury of rat peripheral nerve. Proc Natl Acad Sci U S A (1989) 1.01
Comparison of native E. coli and PEG asparaginase pharmacokinetics and pharmacodynamics in pediatric acute lymphoblastic leukemia. Clin Pharmacol Ther (2009) 1.01
Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain. Neurosci Lett (1999) 1.01
Convergence of PKC-dependent kinase signal cascades on NMDA receptors. Curr Drug Targets (2001) 1.00
Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemia. Leukemia (2004) 1.00
The effects of LY2189265, a long-acting glucagon-like peptide-1 analogue, in a randomized, placebo-controlled, double-blind study of overweight/obese patients with type 2 diabetes: the EGO study. Diabetes Obes Metab (2011) 1.00
Primary hepatocellular carcinoma and hepatitis B virus infection in Korea. J Med Virol (1983) 1.00
Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases. Cancer (1995) 0.99
Identification of hepatitis C viruses with a nonconserved sequence of the 5' untranslated region. J Clin Microbiol (1992) 0.99
Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands. Cancer Res (1995) 0.99
A case report--delayed vesicocutaneous fistula after radiation therapy for advanced vulvar cancer. Ann Acad Med Singapore (1998) 0.99
Two cases of steakhouse syndrome associated with nutcracker esophagus. Dis Esophagus (2002) 0.99
Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats. Hypertension (1994) 0.99
Endoscopic removal of a phytobezoar obstructing the distal small bowel. Gastrointest Endosc (2001) 0.99
Epstein-Barr virus-associated gastric adenocarcinomas among Koreans. Am J Clin Pathol (1996) 0.99
The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br J Plast Surg (2000) 0.98
The NF-kappaB inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemia. Brain Res Bull (2001) 0.98
Nuclear factor-kappa B activation during cerebral reperfusion: effect of attenuation with N-acetylcysteine treatment. Brain Res Mol Brain Res (1998) 0.97
Repair of cardiac defects through a shorter right lateral thoracotomy in children. Ann Thorac Surg (2000) 0.96
Retracted Local erythropoietin signaling enhances regeneration in peripheral axons. Neuroscience (2008) 0.96
Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract. Br J Cancer (1995) 0.96
Facilitated sprouting in a peripheral nerve injury. Neuroscience (2008) 0.96
Diagnosis and management of acute alcohol withdrawal. CMAJ (1999) 0.96
Severe cerebellar degeneration in a patient with T-cell lymphoma. Acta Neuropathol (1986) 0.95
Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ (1999) 0.95
A prospective quantitative study of sensory deficits after whole sural nerve biopsies in diabetic and nondiabetic patients. Surgical approach and the role of collateral sprouting. Neurology (1998) 0.95
Anterior screw fixation of posteriorly displaced type II odontoid fractures. Neurosurgery (1989) 0.95
Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain (1989) 0.95
Novel aspects of the regulation of glycogen storage. J Basic Clin Physiol Pharmacol (1998) 0.95
A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway. Phytomedicine (2010) 0.95
Genome-wide approach to identify risk factors for therapy-related myeloid leukemia. Leukemia (2006) 0.94
Incidence of Guillain-Barré syndrome in Alberta, Canada: an administrative data study. J Neurol Neurosurg Psychiatry (2007) 0.94
Vaccinia topoisomerase and Cre recombinase catalyze direct ligation of activated DNA substrates containing a 3'-para-nitrophenyl phosphate ester. Nucleic Acids Res (2000) 0.94
Sterically stabilized polyplex: ligand-mediated activity. J Control Release (2001) 0.94
Near nerve local insulin prevents conduction slowing in experimental diabetes. Brain Res (1997) 0.93
Cloning, expression and characterization of a novel human REPS1 gene. Biochim Biophys Acta (2001) 0.93